Hold the vial upside down, insert the syringe, and draw the prescribed amount of medication, being careful to avoid air bubbles
Tirzepatide, a dual GIP/GLP-1 receptor agonist, often produces weight loss results at lower doses compared to semaglutide alone, potentially reducing your need for frequent dose adjustments
The GLP-1 receptor agonist liraglutide reduces pathology-specific tau phosphorylation and improves motor function in a transgenic hTauP301L mouse model of tauopathy
IMPORTANT SAFETY INFORMATION: Common side effects: nausea, vomiting, diarrhea, constipation, abdominal discomfort, decreased appetite, and injection-site reactions